Correlation Between T2 Biosystms and Eyepoint Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both T2 Biosystms and Eyepoint Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining T2 Biosystms and Eyepoint Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between T2 Biosystms and Eyepoint Pharmaceuticals, you can compare the effects of market volatilities on T2 Biosystms and Eyepoint Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in T2 Biosystms with a short position of Eyepoint Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of T2 Biosystms and Eyepoint Pharmaceuticals.
Diversification Opportunities for T2 Biosystms and Eyepoint Pharmaceuticals
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between TTOO and Eyepoint is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding T2 Biosystms and Eyepoint Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyepoint Pharmaceuticals and T2 Biosystms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on T2 Biosystms are associated (or correlated) with Eyepoint Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyepoint Pharmaceuticals has no effect on the direction of T2 Biosystms i.e., T2 Biosystms and Eyepoint Pharmaceuticals go up and down completely randomly.
Pair Corralation between T2 Biosystms and Eyepoint Pharmaceuticals
Given the investment horizon of 90 days T2 Biosystms is expected to generate 9.59 times more return on investment than Eyepoint Pharmaceuticals. However, T2 Biosystms is 9.59 times more volatile than Eyepoint Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Eyepoint Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 23.00 in T2 Biosystms on December 3, 2024 and sell it today you would lose (5.00) from holding T2 Biosystms or give up 21.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 75.0% |
Values | Daily Returns |
T2 Biosystms vs. Eyepoint Pharmaceuticals
Performance |
Timeline |
T2 Biosystms |
Eyepoint Pharmaceuticals |
T2 Biosystms and Eyepoint Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with T2 Biosystms and Eyepoint Pharmaceuticals
The main advantage of trading using opposite T2 Biosystms and Eyepoint Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if T2 Biosystms position performs unexpectedly, Eyepoint Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will offset losses from the drop in Eyepoint Pharmaceuticals' long position.T2 Biosystms vs. Intelligent Bio Solutions | T2 Biosystms vs. bioAffinity Technologies, | T2 Biosystms vs. Thermo Fisher Scientific | T2 Biosystms vs. Illumina |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Transaction History View history of all your transactions and understand their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |